Institutional Investor Atlas Venture Files Intent to Sell $1.37M in Dyne Therapeutics Shares

summarizeSummary

Atlas Venture Fund XI, LP intends to sell $1.37 million in Dyne Therapeutics shares, continuing a pattern of significant distribution by the institutional investor.

check_boxKey Events

• Proposed Share Sale

  Atlas Venture Fund XI, LP intends to sell 72,310 shares of common stock, valued at approximately $1,366,659.00.

• Ongoing Institutional Distribution

  This filing continues a pattern of significant share sales by Atlas Venture entities, which have sold over $17 million in Dyne Therapeutics stock in the past week.

• Shareholder Relationship

  The filer, Atlas Venture Fund XI, LP, is identified as a shareholder of Dyne Therapeutics.

auto_awesomeAnalysis

Atlas Venture Fund XI, LP, a significant institutional shareholder, has filed a Form 144 indicating its intent to sell approximately $1.37 million worth of Dyne Therapeutics common stock. This filing is part of a broader, ongoing distribution by Atlas Venture, which has been consistently selling shares over the past week, totaling over $17 million. While the individual transaction is notable, the continuous selling by a major institutional investor could create an overhang on the stock, signaling a reduction in their stake.